Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1514297 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL781110 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL18248568 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL28552027 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL780851 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL3334274 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL9484585 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL3967324 | 1.00 | FDPS (0.44) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL20746522 | 0.96 | CES2 (0.48) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL31351851 | 0.96 | CES2 (0.48) | FDPSSMPD1CES2SCN5ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104418760-B | A kind of amide products production method of continuous dewatering esterase | 江苏磐希化工有限公司 | 2016-12-28 | — | — | CN | claimed |
| CN-104418760-A | Method for continuous water removal production of amide product | JIANGSU PANOXI CHEMICAL CO LTD | 2015-03-18 | — | — | CN | claimed |
| US-8017659-B2 | Proton conductive polymer electrolyte and fuel cell including the same | SAMSUNG SDI CO., LTD. (KR) | 2011-09-13 | — | — | US | claimed |
| US-20080118807-A1 | PROTON CONDUCTIVE POLYMER ELECTROLYTE AND FUEL CELL INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2008-05-22 | — | — | US | claimed |
| EP-0635255-B1 | Process for the stabilisation and reduction of co2 permeability of bicarbonate solution containers made from plasticised PVC | HOSPAL AG (CH) | 1999-07-28 | — | — | EP | claimed |
| EP-0635255-A1 | Process for the stabilisation and reduction of co2 permeability of bicarbonate solution containers made from plasticised PVC | HOSPAL AG (CH) | 1995-01-25 | — | — | EP | claimed |
| CN-108698394-B | Multilayer film for vacuum skin packaging, packaging method and package obtained thereby | 克里奥瓦克公司 | 2021-07-30 | — | — | CN | disclosed |
| EP-3426491-B1 | MULTILAYER FILM FOR VACUUM SKIN PACKAGING, METHOD OF PACKAGING AND PACKAGES OBTAINED THEREWITH | CRYOVAC LLC (US) | 2020-12-02 | — | — | EP | disclosed |
| US-10639866-B2 | Multilayer film for vacuum skin packaging, method of packaging and packages obtained therewith | CRYOVAC, LLC (US) | 2020-05-05 | — | — | US | disclosed |
| US-20190030857-A1 | MULTILAYER FILM FOR VACUUM SKIN PACKAGING, METHOD OF PACKAGING AND PACKAGES OBTAINED THEREWITH | CRYOVAC, INC. (US) | 2019-01-31 | — | — | US | disclosed |
| EP-3426491-A1 | MULTILAYER FILM FOR VACUUM SKIN PACKAGING, METHOD OF PACKAGING AND PACKAGES OBTAINED THEREWITH | Cryovac, Inc. (US) | 2019-01-16 | — | — | EP | disclosed |
| EP-2185359-B1 | DUAL OVENABLE VACUUM SKIN PACKAGED SEALED CONTAINER COMPRISING A RECEPTACLE CONTAINING A FOOD PRODUCT AND A SEALED THERMOFORMABLE POLYESTER FILM LID | DUPONT TEIJIN FILMS US LP (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-3297621-A1 | A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE | Dublin City University (IE) | 2018-03-28 | — | — | EP | disclosed |
| US-20020052370-A1 | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase | PFIZER, INC. | 2002-05-02 | — | — | US | disclosed |
| WO-2002002513-A1 | CYCLOPENTYL-SUBSTITUTED GLUTARAMIDE DERIVATIVES AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE | PFIZER LIMITED (GB) | 2002-01-10 | — | — | WO | disclosed |
| US-6117562-A | A THERMAL IMAGE TRANSFER INK LAYER FORMED ON THE SUPPORT; INK LAYER COMPRISING A COLORING AGENT, A RESIN AND A PLASTICIZER FOR LOWERING THE MELT VISCOSITY OF RESIN | RICOH COMPANY, LTD. (JP) | 2000-09-12 | — | — | US | disclosed |
| EP-0635255-B1 | Process for the stabilisation and reduction of co2 permeability of bicarbonate solution containers made from plasticised PVC | HOSPAL AG (CH) | 1999-07-28 | — | — | EP | disclosed |
| US-5794777-A | PACKAGING FOR FILM | FUJI PHOTO FILM CO., LTD. (JP) | 1998-08-18 | — | — | US | disclosed |
| US-5716477-A | CONSISTS OF A SUPPORT AND THERMAL IMAGE TRANSFER INK LAYER FORMED ON SAID SUPPORT CONSISTS OF A COLORING AGENT AND A PLASTICIZER FOR LOWERING MELT VISCOSITY OF THE RESIN, HIGH THERMOSENSITIVITY ON CLOTH, PLASTIC, OR PAPER RECEIVER | RICOH COMPANY, LTD. (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0635255-A1 | Process for the stabilisation and reduction of co2 permeability of bicarbonate solution containers made from plasticised PVC | HOSPAL AG (CH) | 1995-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052370-A1 | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase | ENGASE, ENPEP, CPN1 | FDPS 1655/4885SMPD1 249/4885CES2 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.